Showing 1 - 2 results of 2 for search 'Xihong Lv', query time: 0.01s
Refine Results
-
1
-
2
Cost-effectiveness analysis of nirsevimab for prevention of respiratory syncytial virus disease among infants in Shanghai, China: A modeling study by Qiang Wang, Jiajin Wu, Lan Li, Zizhe Guo, Bo Zheng, Suyi Zhang, Cui Xiang, Meng Li, Xuefei Qiao, Xihong Lv, Weibing Wang
Published 2025-12-01Get full text
Article